PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.43 - 1.45
1.18 - 2.36
880.0K / 1.73M (Avg.)
-18.00 | -0.08
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
2.34%
Revenue growth under 50% of 1097.HK's 10.88%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
24.74%
Gross profit growth 1.25-1.5x 1097.HK's 17.83%. Bruce Berkowitz would see if strategic sourcing or brand premium explains outperformance.
84.81%
Positive EBIT growth while 1097.HK is negative. John Neff might see a substantial edge in operational management.
2295.40%
Positive operating income growth while 1097.HK is negative. John Neff might view this as a competitive edge in operations.
-42.74%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-57.93%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-61.49%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-7.85%
Share reduction while 1097.HK is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-8.69%
Reduced diluted shares while 1097.HK is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
-34.14%
Negative OCF growth while 1097.HK is at 48.25%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-100.00%
Negative FCF growth while 1097.HK is at 100.00%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
3551.69%
Positive 10Y revenue/share CAGR while 1097.HK is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
146.88%
Positive 5Y CAGR while 1097.HK is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
34.91%
Positive 3Y CAGR while 1097.HK is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
177.47%
Positive long-term OCF/share growth while 1097.HK is negative. John Neff would see a structural advantage in sustained cash generation.
280.14%
5Y OCF/share CAGR above 1.5x 1097.HK's 71.41%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
-37.54%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
93.29%
Net income/share CAGR above 1.5x 1097.HK's 27.62% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
70.78%
Positive 5Y CAGR while 1097.HK is negative. John Neff might view this as a strong mid-term relative advantage.
45.80%
Positive short-term CAGR while 1097.HK is negative. John Neff would see a clear advantage in near-term profit trajectory.
-17.40%
Both are negative. Martin Whitman suspects the segment is in decline or saddled with persistent unprofitability or write-downs.
29.23%
Positive 5Y equity/share CAGR while 1097.HK is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
1.66%
Positive short-term equity growth while 1097.HK is negative. John Neff sees a strong advantage in near-term net worth buildup.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Negative near-term dividend growth while 1097.HK invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
No Data
No Data available this quarter, please select a different quarter.
7.22%
We show growth while 1097.HK is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
-10.57%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-4.71%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-4.67%
We’re deleveraging while 1097.HK stands at 6.94%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-90.19%
We cut SG&A while 1097.HK invests at 53.30%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.